TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited has announced a board meeting scheduled for March 27, 2025, to discuss the approval of the company’s annual results for the year ending December 31, 2024, and to consider recommending a final dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential returns for investors.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a market presence in Hong Kong.
YTD Price Performance: -10.56%
Average Trading Volume: 192,532
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$747.8M
For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.